Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial

Article Abstract:

Pyridoxine (vitamin B6) may be used to treat severe nausea during early pregnancy. Researchers compared the effect of pyridoxine to that of placebo in 336 women less than 17 weeks pregnant with severe nausea. Patients taking pyridoxine reported significantly less nausea than those taking placebo, especially in the first three days of treatment. Pyridoxine has been an ingredient in anti-nausea medications, but this study shows that it may be the only active ingredient. One drug, Debendox (Bendectin in the U.S.), included doxylamine and pyridoxine. Doxylamine has since been found to cause birth defects. This study suggests that pyridoxine by itself may safely and effectively treat severe nausea during early pregnancy.

Author: Vutyavanich, Teraporn, Wongtra-ngan, Supreeya, Ruangsri, Rung-aroon
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1995
Drug therapy, Vomiting, Pregnancy, Complications of, Pregnancy complications, Vitamin B6, Pyridoxine

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Acupressure for the in-patient treatment of nausea and vomiting in early pregnancy: A randomized control trial

Article Abstract:

A study was conducted to evaluate the efficacy of acupressure at the P6 point for the in-patient treatment of severe nausea and vomiting in early pregnancy. The result showed that the use of acupressure at the P6 point does not reduce the amount of antiemetic medication that is required, which is a requirement for intravenous fluid, and median duration of in-patient stay more than the use of placebo.

Author: Heazell, Alexander, Thorneycroft, Joy, Walton, Victoria, Etherington, Ian
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2006
Acupressure, Morning sickness (during pregnancy), Morning sickness

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The efficacy of ginger for the prevention of postoperative nausea and vomiting: A meta-analysis

Article Abstract:

A study is carried out to specifically determine the impact of a fixed dose of ginger administration, compared with placebo, on the 24-hour postoperative nausea and vomiting. The meta-analysis of trials demonstrates that a fixed dose at least 1g of ginger is more effective than placebo for the prevention of postoperative nausea and vomiting.

Author: Chaiyakunapruk, Nathorn, Kitikannakorn, Nantawarn, Nathisuwan, Surakit, Leeprakobboon, Kittiboon, Leelasettagool, Chutchai
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2006
Surgery, Postoperative complications, Ginger

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Prevention, Nausea, Care and treatment, United States
Similar abstracts:
  • Abstracts: Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: A randomized controlled trial
  • Abstracts: Katrina survivors strive to reclaim their lives. A mental health intervention for schoolchildren exposed to violence: a randomized controlled trial
  • Abstracts: Smoking cessation and the risk of stroke in middle-aged men. Role of the metabolic syndrome in risk assessment for coronary heart disease
  • Abstracts: Hepatitis E virus and chronic hepatitis in organ-transplant recipients
  • Abstracts: Pediatric HIV disease, zidovudine in pregnancy, and unblinding heelstick surveys: reframing the debate on prenatal HIV testing
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.